Drug General Information
Drug ID
D0PR9E
Former ID
DNC006484
Drug Name
KMI-596
Drug Type
Small molecular drug
Indication Discovery agent Investigative [530840]
Formula
C34H45N7O9
Canonical SMILES
CC(C)CC(C(=O)NC(CC1=CC=CC=C1)C(C(=O)NC2=CC=CC(=C2)C3=NC<br />(=O)ON3)O)NC(=O)C(C(C)C)NC(=O)C(CCC(=O)O)N
InChI
1S/C34H45N7O9/c1-18(2)15-25(38-32(47)27(19(3)4)39-30(45)23(35)13-14-26(42)43)31(46)37-24(16-20-9-6-5-7-10-20)28(44)33(48)36-22-12-8-11-21(17-22)29-40-34(49)50-41-29/h5-12,17-19,23-25,27-28,44H,13-16,35H2,1-4H3,(H,36,48)(H,37,46)(H,38,47)(H,39,45)(H,42,43)(H,40,41,49)/t23-,24-,25-,27-,28+/m0/s1
InChIKey
WXPDDAQNFBWSRN-WZFFGLSISA-N
PubChem Compound ID
Target and Pathway
Target(s) Beta-secretase Target Info Inhibitor [530840]
References
Ref 530840Bioorg Med Chem. 2010 May 1;18(9):3175-86. Epub 2010 Mar 21.Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.
Ref 530840Bioorg Med Chem. 2010 May 1;18(9):3175-86. Epub 2010 Mar 21.Design of pentapeptidic BACE1 inhibitors with carboxylic acid bioisosteres at P1' and P4 positions.